Eli Lilly: Weight-Loss Money Machine Isn't Slowing Down

Eli Lilly's weight-loss drug, Mounjaro, is expected to generate significant revenue, driving the company's stock price up.

Analysts predict the drug could reach $10 billion in sales by 2026.